Syntegon Pharma Technology is pleased to announce the completion of a major capital investment program with our partners, Parsolex GMP Center. This investment consists of the installation of multiple pieces of equipment to enhance Parsolex’s existing analytical, development and cGMP manufacturing capabilities. The upgraded facility includes a brand new granulation suite complete with a Syntegon PilotMix high shear mixer and PilotLab fluid bed; a tableting suite with a Syntegon TPR 200 tablet press; a capsule filling suite with a Syntegon KKE 1700 capsule checkweigher; and a tablet coating suite utilizing a Syntegon SolidLab 2 drum coater. Parsolex’s significant investment in these top of the line technologies places them as a lead candidate for anyone looking for a solutions partner with the capabilities to provide the highest level of quality and support.
To commemorate this milestone, Syntegon Pharma Technology and Parsolex are excited to invite you to our first jointly hosted technical forum: Solving Scale-Up and Technology Challenges in Batch and Continuous Pharmaceutical Production, which will be hosted both physically and virtually on Tuesday, December 1st, 2020 from 9:00 am-1:00 pm EST.
Additional information including agenda, speakers, and application instructions can be found here:
If you have additional questions, please email Nick.Bade@Syntegon.com . We look forward to seeing you at the forum!
Established in 2004, Parsolex is a world-class contract services company delivering analytical, development, manufacturing, and strategic advisory solutions to clients who are involved with non-sterile pharmaceutical products for clinical trials as well as commercialization. Our clients include leading academic institutions, major hospital systems, start-up’s, virtual companies, and large multi-national pharmaceutical companies from around the globe.
Parsolex GMP Center, Inc
Purdue Research Park
3000 Kent Avenue, Suite 1510
West Lafayette, IN 47906-1169
+1 765.464.8414 (O)
+1 765.464.8408 (F)